MarginsXMarginsX
Home › Markets › Health Care › KALA

KALA BIO Inc. (KALA)

KALA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.83
-8.02% on the day
Market cap
$74.1M
Micro cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$27.0M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1479419/000110465926043782/0001104659-26-043782-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerKALA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2017
SEC CIK0001479419
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$27.0M
Operating income-$39.2M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$7.6M
Total assets$9.5M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
0.1 months
$229K cash at June 30, 2026
Share count, 1 year
+13672.7%
2025-08-07 to 2026-08-14 · +37929.8% over 3 years
Going-concern doubt
No
10-Q filed August 19, 2026
Insider net buying, 12 months
-$958K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-19
Cash and burn$229K cash; operating cash flow -$5.0M a quarter.Report 2026-06-30
Shares outstanding19,339,786 (2026-08-14); 7,021,040 a year earlier; 2,542,716 three years earlier. 1y figure adjusted for splits (1-for-50 overall); 3y figure adjusted for splits (1-for-50 overall).Cover page 2026-08-14
Reverse splits, 3 years1; latest 1-for-50 on 2026-05-11Source 2026-05-11
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-07-22
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-08-28
AuditorHTL International, LLC, Houston, Texas, United States; changed auditors 2 times in 24 months8-K 4.01 2025-12-29
Late filings, 12 months3 NT noticesNT 10-Q 2026-11-13
Insider trades, 12 monthsBought $0, sold $958K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.6M-$1.5M$229KNo debt tagsNeeds four quarters10-Q 2026-08-19
Q1 2026
2026-03-31
Not filed-$1.6M-$2.9M$1.8MNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
Not filed$686K-$4.6M$7.6MNo debt tags$010-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$7.6M-$10.9M$21.1M$26.9MNeeds four quarters10-Q 2025-11-19
Q2 2025
2025-06-30
Not filed-$11.2M-$16.6M$31.9M$26.9MNeeds four quarters10-Q 2026-08-19
Q1 2025
2025-03-31
Not filed-$8.9M-$8.8M$42.2M$29.3MNeeds four quarters10-Q 2026-05-15
Q4 2024
2024-12-31
Not filed-$8.2M-$4.6M$51.2M$29.3M$010-K 2026-04-15
Q3 2024
2024-09-30
Not filed-$8.9M-$4.7M$49.2M$34.0MNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-22
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-19
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-09-24

Source: SEC EDGAR submissions feed, 679 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2569.2%
1 month+1501.5%
3 months+350.6%
Year to date-85.0%
1 year-87.3%
From 52-week high-93.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TLSATiziana Life Sciences Ltd. Common Shares$0.5762+1.11%$73.3M
RANIRani Therapeutics Holdings Inc.$0.5403+2.66%$75.4M
VTVTvTv Therapeutics Inc.$17.69-10.16%$71.0M
COYACoya Therapeutics Inc.$3.00-4.15%$70.4M
CPIXCumberland Pharmaceuticals Inc.$5.21-11.39%$78.1M
CRBPCorbus Pharmaceuticals Holdings Inc.$3.38-0.44%$69.5M
MNOVMedicinova Inc$1.34-3.94%$68.7M
ZYBTZhengye Biotechnology Holding Limited$1.43-4.67%$67.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier